(Q43985087)

28 November 2017

title

The frequency of tumor-infiltrating Tie-2-expressing monocytes in renal cell carcinoma: its relationship to angiogenesis and progression (English)

1 reference

28 November 2017

1 reference

Jindong Ji

1

1 reference

28 November 2017

Guangbo Zhang

2

1 reference

28 November 2017

Bo Sun

3

1 reference

28 November 2017

Hexing Yuan

4

1 reference

28 November 2017

Yuhua Huang

5

1 reference

28 November 2017

Jianglei Zhang

6

1 reference

28 November 2017

Xuedong Wei

7

1 reference

28 November 2017

Xuefeng Zhang

8

1 reference

28 November 2017

Jianquan Hou

9

1 reference

28 November 2017

language of work or name

English

0 references

publication date

12 August 2013

1 reference

28 November 2017

1 reference

28 November 2017

volume

82

1 reference

28 November 2017

issue

4

1 reference

28 November 2017

page(s)

974.e9-13

1 reference

28 November 2017

cites work

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.05.026

Lymphangiogenesis and angiogenesis in conventional renal cell carcinoma: association with vascular endothelial growth factors A to D immunohistochemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.05.026

The relationship of vascular endothelial growth factor and coagulation factor (fibrin and fibrinogen) expression in clear cell renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.05.026

Angiogenesis in renal cell carcinoma: correlation of microvessel density and microvessel area with other prognostic factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.05.026

The role of myeloid cells in the promotion of tumour angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.05.026

Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.05.026

Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.05.026

Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.05.026

Molecular regulation of vessel maturation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.05.026

Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.05.026

Prognostic significance of morphologic parameters in renal cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.05.026

TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.05.026

Angiopoietin-2 regulates gene expression in TIE2-expressing monocytes and augments their inherent proangiogenic functions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.05.026

Expression of Tie-2 by human monocytes and their responses to angiopoietin-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.05.026

Targeting the ANGPT-TIE2 pathway in malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.05.026

Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.05.026

Expression of the angiopoietins and their receptor Tie2 in human renal clear cell carcinomas; regulation by the von Hippel-Lindau gene and hypoxia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.05.026

Expression of angiopoietins in renal epithelial and clear cell carcinoma cells: regulation by hypoxia and participation in angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.05.026

Novel therapies for metastatic renal cell carcinoma: efforts to expand beyond the VEGF/mTOR signaling paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.05.026

Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.05.026

Tumor angiogenesis: therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.05.026

Clinical effect and future considerations for molecularly-targeted therapy in renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.05.026

Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.05.026

Angiogenesis as a therapeutic target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.05.026

Expression of vascular endothelial growth factor protein in human renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.05.026

10.1016/J.UROLOGY.2013.05.026

7 January 2021

Identifiers

DOI

1 reference

28 November 2017

1 reference